(Q38452330)

3 September 2017

Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer (English)

1 reference

3 September 2017

6

Håkan Olsson

1 reference

3 September 2017

Pierre Rudolph

1

1 reference

3 September 2017

Heidi Kühling

2

1 reference

3 September 2017

Per Alm

3

1 reference

3 September 2017

Mårten Fernö

4

1 reference

3 September 2017

Bo Baldetorp

5

1 reference

3 September 2017

Reza Parwaresch

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

International Journal of Cancer

3 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 September 2017

105

1 reference

3 September 2017

5

1 reference

3 September 2017

674-680

1 reference

Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer

3 September 2017

1 reference

21 January 2018

1 reference

Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression

21 January 2018

1 reference

Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions

21 January 2018

1 reference

Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells

21 January 2018

1 reference

Cyclin D1 in breast cancer

21 January 2018

1 reference

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project

21 January 2018

1 reference

Ki-A10, a germ cell nuclear antigen retained in a subset of germ cell-derived tumors

21 January 2018

1 reference

On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.

21 January 2018

1 reference

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

21 January 2018

1 reference

Cyclin E-CDK2 is a regulator of p27Kip1.

21 January 2018

1 reference

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

21 January 2018

1 reference

Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas

21 January 2018

1 reference

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment

21 January 2018

1 reference

Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer. association with prognosis

21 January 2018

1 reference

Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer

21 January 2018

1 reference

The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer

21 January 2018

1 reference

A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells

21 January 2018

1 reference

Cyclin a is required for the onset of DNA replication in mammalian fibroblasts

21 January 2018

1 reference

Role for cyclin A-dependent kinase in DNA replication in human S phase cell extracts

21 January 2018

1 reference

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

21 January 2018

1 reference

Estrogen and progestin regulation of cell cycle progression

21 January 2018

1 reference

ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency

21 January 2018

1 reference

Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells

21 January 2018

1 reference

Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.

21 January 2018

1 reference

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry

21 January 2018

1 reference

Cyclin E, a redundant cyclin in breast cancer

21 January 2018

1 reference

Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line

21 January 2018

1 reference

Cyclin b1 promoter activity and functional cdk1 complex formation in G1 phase of human breast cancer cells

21 January 2018

1 reference

Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation

21 January 2018

1 reference

Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1

21 January 2018

1 reference

Deregulated cyclin E induces chromosome instability

21 January 2018

1 reference

Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines

21 January 2018

1 reference

Repression of cyclin B1 expression after treatment with adriamycin, but not cisplatin in human lung cancer A549 cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.11132

1 reference

3 September 2017

1 reference